Ethyl biscoumacetate

• Description:

  Ethyl biscoumacetate is an anticoagulant and vitamin K antagonist. Ethyl biscoumacetate can be used in the research of experimental venous thrombosis[1][2][3].

• UNSPSC:

  12352005

• Hazard Statement:

  H315-H319-H320

• Target:

  Biochemical Assay Reagents

• Related Pathways:

  Others

• Field of Research:

  Cardiovascular Disease

• Smiles:

  O=C(OCC)C(C1=C(O)C2=CC=CC=C2OC1=O)C3=C(O)C4=CC=CC=C4OC3=O

• Molecular Formula:

  C22H16O8

• Molecular Weight:

  408.36

• Precautions:

  P264-P280-P302+P352-P305+P351+P338-P362

• References & Citations:

  [1]CHATTERJEA JB, et al. Antagonistic effect of A.C.T.H. and cortisone on the anticoagulant activity of ethyl biscoumacetate. Br Med J. 1954 Oct 2;2 (4891) :790-2. |[2]Sharaev P N, et al. Aortic glycosaminoglycans in avitaminosis. Bulletin of Experimental Biology and Medicine, 1979, 88 (1) : 733-734. |[3]JEWELL P, et al. Heparin and ethyl biscoum-acetate in prevention of experimental venous thrombosis. Br Med J. 1954 May 1;1 (4869) :1013-6.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [548-00-5]